40,95 €
40,95 €
inkl. MwSt.
Sofort per Download lieferbar
40,95 €
40,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
Als Download kaufen
40,95 €
inkl. MwSt.
Sofort per Download lieferbar
Jetzt verschenken
40,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
  • Format: PDF

This pocketbook is an evidence-based educational resource that provides a concise overview of diagnosis, treatment and long-term management of relapsing-remitting multiple sclerosis. An ideal clinical handbook for a wide range of medical professionals, this handbook includes international guidelines, clinically relevant clinical trial data, and an introduction to emerging therapies. Handbook of Relapsing-Remitting Multiple Sclerosis is a comprehensive overview of recent advances in this indication, enhanced by high quality figures and clinical images.

Produktbeschreibung
This pocketbook is an evidence-based educational resource that provides a concise overview of diagnosis, treatment and long-term management of relapsing-remitting multiple sclerosis. An ideal clinical handbook for a wide range of medical professionals, this handbook includes international guidelines, clinically relevant clinical trial data, and an introduction to emerging therapies. Handbook of Relapsing-Remitting Multiple Sclerosis is a comprehensive overview of recent advances in this indication, enhanced by high quality figures and clinical images.

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Dr. Aaron Miller is a member of the Board of Directors of the American Academy of Neurology, and serves as Editor of Continuum, the AAN's bimonthly continuing education publication. He is active in the New York City chapter of the National Multiple Sclerosis Society, where he serves as Chairman of the Clinical Advisory Committee. He is a past president of the Consortium of MS Centers, and was the first chairman of the Multiple Sclerosis section of the American Academy of Neurology. He has participated in numerous MS clinical trials, and is the principal investigator for several ongoing trials of new treatments at the CGD Center.
Rezensionen
"This is a well-considered and concise review of where we are currently 'at' with relapsing-remitting multiple sclerosis. ... This is a reliable, practical introduction to the rapidly evolving and expanding area of multiple sclerosis, for those wishing to enter the field of neurologists seeking a better understanding of it." (Victoria Singh-Curry, British Journal of Hospital Medicine, Vol. 78 (8), August, 2017)